Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018902 · ClinicalTrials.gov registry record · Phase 2
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 334
- Enrollment target
NCT00018902: Completed Phase 2 study, sponsored by University of Pittsburgh.
NCT00018902 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 334 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (151% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018902, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 334 participants
- Enrollment target
Study Summary
The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- DRUG Fluoxetine
- DRUG Citalopram
- DRUG Venlafaxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2001-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00018902 record still lists
NCT00018902 is an interventional study that assigns participants to a tested intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (151% higher).
The record links to 0 conditions, and to 4 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT00018902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00018902 about?
NCT00018902 is a clinical study titled "Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)". The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
What is the current status of trial NCT00018902?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 334 participants. The study started on 2001-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00018902?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Fluoxetine (DRUG), Citalopram (DRUG), Venlafaxine (DRUG).
Who is sponsoring clinical trial NCT00018902?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00018902's enrollment target sits among peer trials
334 143rd of 2000 higher than 1,857 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia